Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Top Publications
Davies, C, Marshall, HS, Brotherton, JML, McCaffery, K, Kang, M, Macartney, K, Garland, SM, Kaldor, J, Zimet, G, Skinner, SR, et al.
Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial.
Preventive Medicine
172:
107542
2023
view publication
Murray, GL, Plummer, EL, Bodiyabadu, K, Vodstrcil, LA, Huaman, JL, Danielewski, JA, Chua, TP, Machalek, DA, Garland, S, Doyle, M, et al.
gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
Clinical Infectious Diseases
76(12)
:
2187 -2195
2023
view publication
Phillips, S, Cornall, AM, Molano, M, Jin, F, Roberts, JM, Farnsworth, A, Hillman, RJ, Templeton, DJ, Poynten, IM, Garland, SM, et al.
Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade Lesions..
The Journal of Infectious Diseases
227(12)
:
1407 -1416
2023
view publication
Velentzis, LS, Hawkes, D, Caruana, M, Brotherton, JM, Smith, MA, Roeske, L, Karim, KA, Garland, SM, Wrede, CD, Tan, J, et al.
Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening.
Tumour Virus Research
15:
200255
2023
view publication
Sharma, K, Machalek, DA, Toh, ZQ, Amenu, D, Muchengeti, M, Ndlovu, AK, Mremi, A, Mchome, B, Vallely, AJ, Denny, L, et al.
No woman left behind: achieving cervical cancer elimination among women living with HIV.
The Lancet HIV
10(6)
:
e412 -e420
2023
view publication